Disparities in access to Dolutegravir in children, adolescents and young adults aged 0-24 years living with HIV in West Africa. A cohort analysis.
Sophie DesmondeJoycelyn Assimeng DameKaren MalatesteAgatha N DavidMadeleine Amorissani-FolquetSylvie N'GbecheMariam SyllaElom TakassiKouadio KouakouLehila Bagnan TossaCaroline YonabaValeriane Leroynull nullPublished in: medRxiv : the preprint server for health sciences (2024)
Children and adolescent males ≥ 5 years, on NNRTIs, with access to VL were the most likely to switch to DTG. As DTG access scales up, updated documentation of treatment practices is required to better ensure universal and equal access.